Pediatric Oncology Flashcards
_____ is the most common childhood malignancy followed by ____ and ____.
ALL followed by CNS tumors and lymphomas.
ALL accounts for approx. ___ % of all childhood leukemias.
~97%
ALL is a/w ____ disorders/conditions.
-Down syndrome (trisomy 21)
-Fanconi anemia
-Prior radiation
-SCID
-congenital bone marrow failure states (Diamond-Blackfan anemia etc.)
ALL in children has a good prognosis with a 5-year survival rate of ___ %.
> 85%
____ demographic groups have the highest incidence of ALL.
non-hispanic white male children between 2-5 years of age.
AML is most commonly seen in ___ demographic groups.
black boys throughout childhood.
Symptoms of ALL are ____ (? gradual, abrupt) in onset.
abrupt
Clinical presentation of acute leukemia (ALL, AML) is marked by abrupt onset of ______ s/s (list most).
-Initial non-specific: anorexia, fatigue, weight loss.
-Bone pain with a limp/refusal to bear weight.
-Fever d/t Neutropenia,
-Pallor d/t anemia,
-Ecchymoses, petechiae d/t thrombocytopenia,
and/or
-hepatosplenomegaly
-Lymphadenopathy.
Acute leukemias are characterized by greater than ____ % blasts in the peripheral blood smear or on bone marrow leading to a more rapid onset of symptoms.
In contrast, chronic leukemia has less than _____ % blasts with a relatively chronic onset of symptoms.
Acute leukemias > 20% blasts in the PBS/BM;
Chronic leukemia < 20% blasts in PBS/BM.
The accelerated/blast phase is a transformation of ____ leukemia into an acute phase with a significantly higher degree of blasts.
The accelerated/blast phase is a transformation of CML into an acute phase with a significantly higher degree of blasts.
True/False?
The WBC count is usually very high in leukemia.
False;
WBC count may be low, normal, or high in leukemia.
Tumor lysis syndrome is marked by ____ electrolyte disturbances.
MN: PUKE Calcium
P: Hyperphosphatemia
U: Hyperuricemia
K: Hyperkalemia
C: HYPOcalcemia (as phosphate released from lysed tumor cells binds with calcium).
What are the life-threatening sequelae of electrolyte imbalances seen in tumor lysis syndrome?
-acute renal failure
-arrhythmias
-death
____ pharmaceutical agents can precipitate tumor lysis syndrome.
Corticosteroids
______ can be used to reduce the risk of hyperuricemia- aka urate-induced nephropathy in patients undergoing chemotherapeutic treatment for leukemia.
Rasburicase
*rapidly lowers existing hyperuricemia.
_____ can be used as a hyperuricemia preventative agent in leukemia patients starting chemotherapy.
Allopurinol
____ is an embryonal tumor of neural crest origin, similar to a pheochromocytoma.
neuroblastoma